Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 10-Q Report Quarterly Report
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Insider Changes in Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 10-Q Report Quarterly Report
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 8-K Event Bylaws or fiscal year change · Other events
  14. 4 Insider Changes in Ownership
  15. 424B4 Offering Prospectus
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. EFFECT Other Notice of Effectiveness
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 22 of 24 · 467 filings